FcγRIIa, not FcγRIIb, is constitutively and functionally expressed on skin-derived human mast cells

Journal of Immunology

Volumn 177, Issue 1, 2006, Pages 694-701

  Zhao, Wei ^a   Kepley, Christopher L ^a   Morel, Penelope A ^b   Okumoto, Lawrence M ^a   Fukuoka, Yoshihiro ^a   Schwartz, Lawrence B ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; DER P2 ALLERGEN; FC EPSILON RECEPTOR I; FC GAMMA RECEPTOR I; FC GAMMA RECEPTOR IIA; FC GAMMA RECEPTOR IIB; FC GAMMA RECEPTOR III; FC RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE C4; MESSENGER RNA; MONOCLONAL ANTIBODY; PROSTAGLANDIN D2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RELEASE; DERMATOPHAGOIDES; FLOW CYTOMETRY; GENE CHIP; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN; WESTERN BLOTTING;

EID: 33745323582     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.1.694     Document Type: Article

References (57)

1. Unkeless, J. C., and J. Jin. 1997. Inhibitory receptors, ITIM sequences and phosphatases. Curr. Opin. Immunol. 9: 338-343.
2. Malaviya, R., and A. Georges. 2002. Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin. Rev. Allergy Immunol. 22: 189-204.
3. + cells in HIV-1 infection. Immunological Reviews. 179: 128-138.
4. Marshall, J. S., C. A. King, and J. D. McCurdy. 2003. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr. Pharm. Des. 9: 11-24.
5. Urban, J. F., L. Schopf, S. C. Morris, T. Orekhova, K. B. Madden, C. J. Betts, H. R. Gamble, C. Byrd, D. Donaldson, K. Else, and F. D. Finkelman. 2000. Stato signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J. Immunol. 164: 2046-2052.
6. Knight, P. A., S. H. Wright, C. E. Lawrence, Y. Y. Paterson, and H. R. Miller. 2000. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192: 1849-1856.
7. Sylvestre, D. L., and J. V. Ravetch. 1996. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity. 5: 387-390.
8. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
9. Robbie-Ryan, M., M. B. Tanzola, V. H. Secor, and M. A. Brown. 2003. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170: 1630-1634.
10. Okayama, Y., A. S. Kirshenbaum, and D. D. Metcalfe. 2000. Expression of a functional high-affinity IgG receptor, Fcγ RI, on human mast cells: up-regulation by IFN-γ. J. Immunol. 164: 4332-4339.
11. Chong, H. J., B. L. Andrew, D. P. Bailey, H. Wright, C. Ramirez, A. Gharse, C. Oskeritzian, H. Z. Xia, J. Zhu, W. E. Paul, et al. 2003. IL-4 selectively enhances FcγRIII expression and signaling on mouse mast cells. Cell Immunol. 224: 65-73.
12. Daeron, M. 2000. Fc receptors and allergies. Rev. Fr. Allergol. 40: 445-465.
13. Daeron, M., O. Malbec, S. Latour, M. Arock, and W. H. Fridman. 1995. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest. 95: 577-585.
14. Daeron, M., S. Latour, O. Malbec, E. Espinosa, P. Pina, S. Pasmans, and W. H. Fridman. 1995. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fcγ RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3: 635-646.
15. Lesourne, R., W. H. Fridman, and M. Daeron. 2005. Dynamic interactions of Fcγ receptor IIB with filamin-bound SHIP1 amplify filamentous actin-dependent negative regulation of Fcε receptor I signaling. J. Immunol 174: 1365-1373.
16. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII- deficient mice. Nature 379: 346-349.
17. Ujike, A., Y. Ishikawa, M. Ono, T. Yuasa, T. Yoshino, M. Fukumoto, J. V. Ravetch and T. Takai. 1999. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. 189: 1573-1579.
18. Ghannadan, M., M. Baghestanian, F. Wimazal, M. Eisenmenger, D. Latal, G. Kargül, S. Walchshofer, C. Sillaber, K. Lechner, and P. Valent. 1998. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J. Invest. Dermatol. 111: 689-695.
19. Valent, P., L. K. Ashman, W. Hinterberger, F. Eckersberger, O. Majdic, K. Lechner, and P. Bettelheim. 1989. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 7: 1778-1785.
20. Tam, S. W., S. Demissie, D. Thomas, and M. Daeron. 2004. A bispecific antibody against human IgE and human FcγRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 59: 772-780.
21. Yamada, T., D. Zhu, K. Zhang, and A. Saxon. 2003. Inhibition of interleukin-4-induced class switch recombination by a human immunoglobulin Fcγ-Fc epsilon chimeric protein. J. Biol. Chem. 278: 32818-32824.
22. Kepley, C. L., K. Zhang, D. Zhu, and A. Saxon. 2003. FcεRI- FcγRII coaggregation inhibits IL-16 production from human Langerhans-like dendritic cells. Clin. Immunol. 108: 89-94.
23. Zhang, K., C. L. Kepley, T. Terada, D. Zhu, H. Perez, and A. Saxon. 2004. Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein. J. Allergy Clin. Immunol. 114: 321-327.
24. Kepley, C. L., S. Taghavi, G. A. Mackay, D. Zhu, P. A. Morel, K. Zhang, J. J. Ryan, L. S. Satin, M. Zhang, P. P. Pandolfi, and A. Saxon. 2004. Coaggregation of Fcγ RII With Fcε RI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. J. Biol. Chem.
25. Kambe, N., M. Kambe, I. P. Kochan, and L. B. Schwartz. 2001. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97: 2045-2052.
26. Riske, F., J. Hakim, M. Mallamaci, M. Griffin, B. Pilson, N. Tobkes, P. Lin, W. Danho, J. Kochan, and R. Chizzonite. 1991. High affinity human IgE receptor (FcεRI). Analysis of functional domains of the α-subunit with monoclonal antibodies. J. Biol. Chem. 266: 11245-11251.
27. Antoun, G. R., B. M. Longenecker, and T. F. Zipf. 1989. Comparison of the 40 kDa hematopoietic cell antigens bound by monoclonal antibodies IV. 3, 41H. 16 and KB61. Mol. Immunol. 26: 333-338.
28. Tridandapani, S., K. Siefker, J. L. Teillaud, J. E. Carter, M. D. Wewers, and C. L. Anderson. 2002. Regulated expression and inhibitory function of Fcγ RIIb in human monocytic cells. J. Biol. Chem. 277: 5082-5089.
29. Vely, F., N. Gruel, J. Moncuit, O. Cochet, H. Rouard, S. Dare, J. Galon, C. Sautes, W. H. Fridman, and J. L. Teillaud. 1997. A new set of monoclonal antibodies against human Fcγ RII (CD32) and Fcγ RIII (CD16): characterization and use in various assays. Hybridoma 16: 519-528.
30. Micklem, K. J., W. P. Stress, A. C. Willis, J. L. Cordell, M. Jones, and D. Y. Mason. 1990. Different isoforms of human FcRII distinguished by CDw32 antibodies. J. Immunol. 144: 2295-2303.
31. Looney, R. J., G. N. Abraham, and C. L. Anderson. 1986. Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J. Immunol 136: 1641-1647.
32. 2 derivative for recruitment of cytotoxic effectors. Mol. Immunol. 28: 1243-1254.
33. Smith, A. M., D. C. Benjamin, N. Hozic, U. Derewenda, W. A. Smith, W. R. Thomas, G. Gafvelin, M. Hage-Hamsten and M. D. Chapman. 2001. The molecular basis of antigenic cross-reactivity between the group 2 mite allergens. J. Allergy Clin. Immunol. 107: 977-984.
34. Schuurman, J., G. J. Perdok, T. E. Lourens, P. W. Parren, M. D. Chapman, and R. C. Aalberse. 1997. Production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen-specific IgE. J. Allergy Clin. Immunol 99: 545-550.
35. Van der Zee, J. S., P. van Swieten, H. M. Jansen, and R. C. Aalberse. 1988. Skin tests and histamine release with P1-depleted Dermalophagoides pteronyssinus body extracts and purified P1. J. Allergy Clin. Immunol 81: 884-896.
36. Kepley, C. L., J. C. Cambier, P. A. Morel, D. Lujan, E. Onega, B. S. Wilson, and J. M. Oliver. 2000. Negative regulation of Fc epsilon RI signaling by Fc gamma RII costimulation in human blood basophils. J. Allergy Clin. Immunol. 106: 337-348.
37. Metes, D., L. K. Ernst, W. H. Chambers, A. Sulica, R. B. Herberman, and P. A. Morel. 1998. Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcγRIIC gene. Blood 91: 2369-2380.
38. Schwartz, L. B., R. A. Lewis, D. Seldin, and K. F. Austen. 1981. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 126: 1290-1294.
39. Schwartz, L. B., T. R. Bradford, C. Rouse, A.-M. Irani, G. Rasp, J. K. Van der Zwan, and P.-W. G. Van Der Linden. 1994. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol. 14: 190-204.
40. Zhao, W., C. A. Oskeritzian, A. L. Pozez, and L. B. Schwartz. 2005. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175: 2635-2642.
41. Ovsyannikova, I. G., L. D. Vailes, Y. Li, P. W. Heymann, and M. D. Chapman. 1994. Monoclonal antibodies to group II Dermatophagoides spp. allergens: murine immune response, epitope analysis, and development of a two-site ELISA. J. Allergy Clin. Immunol. 94: 537-546.
42. Warmerdam, P. A., van den Herik-Oudijk, I. E., P. W. Parren, N. A. Westerdaal, J. G. van de Winkel, and P. J. Capel. 1993. Interaction of a human FcγRIIb1 (CD32) isoform with murine and human IgG subclasses. Int. Immunol. 5: 239-247.
43. Ierino, F. L., M. D. Hulett, I. F. McKenzie, and P. M. Hogarth. 1993. Mapping epitopes of human FcγRII (CDw32) with monoclonal antibodies and recombinant receptors. J. Immunol. 150: 1794-1803.
44. 1-dependent passive anaphylaxis. J. Clin. Invest. 99: 901-914.
45. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15: 203-234.
46. Ott, V. L., and J. C. Cambier. 2000. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? J. Allergy Clin. Immunol. 106: 429-440.
47. Katz, H. R. 2002. Inhibitory receptors and allergy. Curr. Opin. Immunol. 14: 698-704.
48. Zhu, D., C. L. Kepley, M. Zhang, K. Zhang, and A. Saxon. 2002. A novel human immunoglobulin Fcγ Fcε bifunctional fusion protein inhibits Fcε RI-mediated degranulation. Nat. Med. 8: 518-521.
49. Oskeritzian, C. A., W. Zhao, H. K. Min, H. Z. Xia, A. Pozez, J. Kiev, and L. B. Schwartz. 2005. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J. Allergy Clin. Immunol. 115: 1162-1168.
50. Lawrence, I. D., J. A. Warner, V. L. Cohan, W. C. Hubbard, A. Kagey-Sobotka, and L. M. Lichtenstein. 1987. Purification and characterization of human skin mast cells. J. Immunol. 139: 3062-3069.
51. Columbo, M., E. M. Horowitz, L. M. Botana, D. W. MacGlashan, Jr., B. S. Bochner, S. Gillis, K. M. Zsebo, S. J. Galli, and L. M. Lichtenstein. 1992. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol. 149: 599-608.
52. Coopman, P. J., M. T. Do, M. Barth, E. T. Bowden, A. J. Hayes, E. Basyuk, J. K. Blancato, P. R. Vezza, S. W. McLeskey, P. H. Mangeat, and S. C. Mueller. 2000. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature. 406: 742-747.
53. Burks, W., R. Helm, S. Stanley, and G. A. Bannon. 2001. Food allergens. Curr. Opin. Allergy Clin. Immunol. 1: 243-248.
54. Jiang, Y., S. Hirose, M. Abe, R. Sanokawa-Akakura, M. Ohtsuji, X. Mi, N. Li, Y. Xiu, D. Zhang, J. Shirai, et al. 2000. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51: 429-435.
55. Su, K., J. Wu, J. C. Edberg, X. Li, P. Ferguson, G. S. Cooper, C. D. Langefeld, and R. P. Kimberly. 2004. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcγRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J. Immunol. 172: 7186-7191.
56. Blank, M. C., R. N. Stefanescu, E. Masuda, F. Marti, P. D. King, P. B. Redecha, R. J. Wurzburger, M. G. Peterson, S. Tanaka, and L. Pricop. 2005. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum. Genet. 117: 220-227.
57. Ernst, L. K., D. Metes, R. B. Herberman, and P. A. Morel. 2002. Allelic polymorphisms in the FcγRIIC gene can influence its function on normal human natural killer cells. J Mol. Med. 80: 248-257.